Literature DB >> 32370466

[Characteristics of peripheral blood leukocyte differential counts in patients with COVID-19].

Y X Li1, W Wu1, T Yang2, W Zhou1, Y M Fu1, Q M Feng1, J M Ye1.   

Abstract

To investigate the early changes of peripheral blood leukocyte differential counts in patients with COVID-19. Ten patients with COVID-19 and 30 patients with other viral pneumonia (non-COVID-19) admitted to The Sixth People's Hospital of Shanghai and Jinshan Branch Hospital from January 22 to February 17, 2020 were enrolled in this study. The differential counts of white blood cells (WBC) were analyzed. Patients in COVID-19 group showed relatively lower absolute WBC count 4.95(3.90,6.03)×10(9)/L, lymphocyte absolute count 1.20(0.98,1.50)×10(9)/L and eosinophil absolute count 0.01(0.01,0.01)×10(9)/L. Leukopenia developed in two patients(2/10), lymphocytopenia also in two patients(2/10). Seven over ten patients presented with eosinophil cytopenia. In non-COVID-19 group, absolute WBC count was 8.20(6.78,9.03)×10(9)/L (P<0.001), lymphocyte absolute count 1.75(1.20,2.53)×10(9)/L(P=0.036), eosinophil absolute count 0.02(0.01,0.03)×10(9)/L(P=0.005). Lymphocytopenia occurred in 16.7% patients, eosinophil cytopenia in 16.7% patients too. In conclusion, leukopenia, lymphocytopenia and eosinophil cytopenia are more common in COVID-19 patients than those in non-COVID-19 patients.

Entities:  

Keywords:  COVID-19; Eosinophil; Viral pneumonia

Mesh:

Year:  2020        PMID: 32370466     DOI: 10.3760/cma.j.cn112138-20200221-00114

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  4 in total

1.  An Explainable System for Diagnosis and Prognosis of COVID-19.

Authors:  Jiayi Lu; Renchao Jin; Enmin Song; Mubarak Alrashoud; Khaled N Al-Mutib; Mabrook S Al-Rakhami
Journal:  IEEE Internet Things J       Date:  2020-11-13       Impact factor: 10.238

Review 2.  Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.

Authors:  Jitendra Kumar Chaudhary; Rohitash Yadav; Pankaj Kumar Chaudhary; Anurag Maurya; Nimita Kant; Osamah Al Rugaie; Hoineiting Rebecca Haokip; Deepika Yadav; Rakesh Roshan; Ramasare Prasad; Apurva Chatrath; Dharmendra Singh; Neeraj Jain; Puneet Dhamija
Journal:  Cells       Date:  2021-10-29       Impact factor: 6.600

3.  Activated CD8+CD38+ Cells Are Associated With Worse Clinical Outcome in Hospitalized COVID-19 Patients.

Authors:  Anna Bobcakova; Martina Barnova; Robert Vysehradsky; Jela Petriskova; Ivan Kocan; Zuzana Diamant; Milos Jesenak
Journal:  Front Immunol       Date:  2022-03-14       Impact factor: 7.561

Review 4.  Immune Parameters and COVID-19 Infection - Associations With Clinical Severity and Disease Prognosis.

Authors:  Milos Jesenak; Miroslava Brndiarova; Ingrid Urbancikova; Zuzana Rennerova; Jarmila Vojtkova; Anna Bobcakova; Robert Ostro; Peter Banovcin
Journal:  Front Cell Infect Microbiol       Date:  2020-06-30       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.